A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Grit Biotechnology
Grit Biotechnology
Roswell Park Cancer Institute
Advice Pharma Group srl
Instituto de Investigación Biomédica de Salamanca
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Sandoz